Showing results (91-100 of 686) with videos related to

Sort By:
Pageof 69
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1987
Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary and cardiac side effects of the drugJ Verweij, M E van der Burg, H M Pinedo
Journal of Cancer Research and Clinical Oncology|January 1, 1986
The difference in pharmacokinetics of mitomycin C, given either as a single agent or as a part of combination chemotherapyJ Verweij, M Stuurman, J de Vries, et al.
Cancer Letters|March 1, 1981
Determination of thioproline in plasma using high performance liquid chromatographyJ Lankelma, P G Penders, A Leyva, et al.
Biochemical Pharmacology|September 28, 1995
The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicityH S Mülder, H Dekker, H M Pinedo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Current chemotherapeutic possibilities in the treatment of colorectal cancerB van Triest, C J van Groeningen, H M Pinedo
Cancer Metastasis Reviews|February 8, 2002
Adjuvant treatment of colorectal cancer: towards tumor-specific immunotherapiesA J van den Eertwegh, A Baars, H M Pinedo
Analytical Biochemistry|February 15, 1987
A sensitive, nonradiometric assay for dihydroorotic acid dehydrogenase using anion-exchange high-performance liquid chromatographyG J Peters, E Laurensse, A Leyva, et al.
British Journal of Cancer|September 6, 2000
Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenograftsG M Kolfschoten, T M Hulscher, H M Pinedo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancerE Boven, H M Schlüper, C A Erkelens, et al.
Cancer Research|February 1, 1977
The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusionH M Pinedo, D S Zaharko, J Bull, et al.
Pageof 69